樋本祐紀 (Yuki Himoto) - マイポータル

基本情報

所属: 京都大学医学部附属病院放射線診断科特定病院助教

研究者番号: 30838991
ORCID ID: https://orcid.org/0000-0001-8508-8221
J-GLOBAL ID: 202001017080784380

研究分野

ライフサイエンス / 放射線科学 /

論文

Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan.

Yuki Himoto, Akihiko Sakata, Mitsuhiro Kirita, Takashi Hiroi, Ken-Ichiro Kobayashi, Kenji Kubo, Hyunjin Kim, Azusa Nishimoto, Chikara Maeda, Akira Kawamura, Nobuhiro Komiya, Shigeaki Umeoka

Japanese journal of radiology 38(5) 400 - 406 2020年5月査読有り
Computed Tomography–Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer

Yuki Himoto, Harini Veeraraghavan, Junting Zheng, Dmitriy Zamarin, Alexandra Snyder, Marinela Capanu, Stephanie Nougaret, Hebert A. Vargas, Fuki Shitano, Margaret Callahan, Wei Wang, Evis Sala, Yulia Lakhman

JCO Precision Oncology (3) 1 - 13 2019年11月査読有り
Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?

Yuki Himoto, Paulina Cybulska, Fuki Shitano, Evis Sala, Junting Zheng, Marinela Capanu, Stephanie Nougaret, Ines Nikolovski, Hebert A Vargas, Wei Wang, Jennifer J Mueller, Dennis S Chi, Yulia Lakhman

Gynecologic oncology 155(2) 192 - 200 2019年11月査読有り
What is the most suitable MR signal index for quantitative evaluation of placental function using Half-Fourier acquisition single-shot turbo spin-echo compared with T2-relaxation time?

Kyoko Nakao Kameyama, Aki Kido, Yuki Himoto, Yusaku Moribata, Sachiko Minamiguchi, Ikuo Konishi, Kaori Togashi

Acta radiologica (Stockholm, Sweden : 1987) 59(6) 748 - 754 2018年6月査読有り
A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion Coefficient.

Ryo Kuwahara, Aki Kido, Shiro Tanaka, Kaoru Abiko, Kyoko Nakao, Yuki Himoto, Naoko Nishio, Yasuhisa Kurata, Masaki Mandai, Kaori Togashi

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 28(5) 861 - 868 2018年6月査読有り

もっとみる

MISC

A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial)

Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Laxmi Parida, Satoshi Morita, Masakazu Toi

CANCER RESEARCH 80(4) 2020年2月